Cargando…
COVID-19 vaccines: Considering sex differences in efficacy and safety
The development of SARS-CoV-2 vaccines represents a significant breakthrough for managing the COVID-19 pandemic. However, their approval process has exposed a crucial limitation in clinical trial reports—that is, a disregard for sex differences in response to vaccines. Historically, males and female...
Autores principales: | Jensen, Adelaide, Stromme, Masha, Moyassari, Shayda, Chadha, Antonella Santuccione, Tartaglia, Maria Carmela, Szoeke, Cassandra, Ferretti, Maria Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824304/ https://www.ncbi.nlm.nih.gov/pubmed/35149232 http://dx.doi.org/10.1016/j.cct.2022.106700 |
Ejemplares similares
-
Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
por: Castro-Aldrete, Laura, et al.
Publicado: (2023) -
Digital biomarkers and sex impacts in Alzheimer’s disease management — potential utility for innovative 3P medicine approach
por: Harms, Robbert L., et al.
Publicado: (2022) -
Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System
por: Gruber, Oliver, et al.
Publicado: (2014) -
Simulating SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing app containment
por: Ferrari, Alberto, et al.
Publicado: (2021) -
Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare
por: Cirillo, Davide, et al.
Publicado: (2020)